Jubilant Pharmova Ltd
Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws, And To Approve Seeking Shareholders'' Approval, As May Be Required
01 / The disclosure
What the company shared
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve To consider and approve raising of funds through the issuance of Non-Convertible Debentures (NCDs) and/or such other securities as may be permitted under applicable laws, and to approve seeking shareholders'' approval, as may be required
A question for your research
Confirm the meeting date and reporting period. A scheduled meeting or trading-window closure does not establish that results have been released.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 2e382505-3975-4d78-b4c7-ad625ed899b6
- First collected
- 7 Oct 2026, 21:05 IST
- PDF extraction
- pending